[Levamisol and cell-mediated immunity in sarcoidosis (author's transl)].
In patients with clinically and histologically confirmed sarcoidosis the question was investigated whether Levamisol shows any therapeutical effectively on this disease. With application of Levamisol neither the deficiency of cell-mediated immunity in vivo (PPD and streptokinase) nor the in-vitro tests (blast-transformation of lymphocytes, E-rosettes) was influenced.
D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects*; D007978:Levamisole / Q000494:pharmacology / Q000627:therapeutic use*; D008213:Lymphocyte Activation / Q000187:drug effects; D012397:Rosette Formation; D012507:Sarcoidosis / Q000188:drug therapy* / Q000276:immunology
D007978:Levamisole
Levamisol und zellenvermittelte Immunität bei Sarkoidose.